Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Philips Gets More Connected

This article was originally published in Clinica

Executive Summary

Philips is collaborating with US digital health connectivity specialist Validic to bring consumer-generated health data into HealthSuite, Philips’ open cloud-based platform that collects, integrates and analyzes health, wellness and clinical data to improve patient care and enable people to better manage their own health. Validic’s connectivity platform reaches out to around 223 million people in 47 countries. Philips aims to use Validic’s technology to further enhance the integration of data from fitness wearables, remote monitoring devices and health apps, as well as medical device like blood pressure cuffs, health patches and glucose meters, into its existing and new connected health services. These include Philips’ Personal Health Programs, Lifeline medical alert services and eCareCoordinator and eCareCompanion eHealth.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT103179

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel